MurciaSalud

Los investigadores del grupo de Cardiogenética de la Universidad de Murcia (UMU) y el Instituto Murciano de Investigación Biosanitaria (IMIB) María Sabater y Juan Ramón Gimeno han obtenido una ayuda dotada de un millón de euros para mejorar el diagnóstico y tratamiento de la miocardiopatia hipertrófica, una enfermedad cardiaca hereditaria que afecta a una de cada 500 personas.

Hypertrophic cardiomyopathy is characterized by an increase in cardiac thickness that cannot be explained by abnormal loading conditions alone. This heart disease can manifest itself in various ways, one of them, as obstruction of the left ventricular outflow tract, causing in many cases a significant obstructive gradient that impacts the patient's quality of life. Elisabete Alzola, Juan Ramón Gimeno, Esther González and Julián Palomino review the treatment possibilities before considering the invasive approach in CardioPODCAST.

Currently, cardiovascular control focuses on rhythm, heart rate and the prevention of cardioembolic stroke through correct anticoagulation based on the characteristics of each patient. But is it enough in the proper management of atrial fibrillation? Cardiologists Carmen González de la Portilla, Lorenzo Fácila and Manuel Almendro with internist Carmen Suárez answer this and other questions in a new episode.

The disease is inherited and causes a thickening of the heart muscle. Five Murcian patients have had the opportunity to successfully test the results of the new drug

About thirty patients in the Region share an alteration that causes severe cardiomyopathy with about a thousand Dutch people

Francisco Mojica, from salt lakes to the lottery of the Nobel | Visionarios |El País Semanal

This book gathers all topics related to physical exercise, sport and the heart in order to help practice safely, regardless of the individual condition of the person practicing.